A/Prof Rebecca Lim holds dual appointments at the Department of Obstetrics and Gynaecology at Monash University and Deputy Director of The Ritchie Centre, Hudson Institute of Medical Research. She is also an adjunct Research Group Leader at the Australian Regenerative Medicine Institute. A/Prof Lim pioneered the clinical use of allogeneic amniotic epithelial cells (hAEC). She led a dynamic team of biomedical and clinician scientists to completing a first-in-human hAEC trial in extremely premature babies with establishing severe lung disease. She is currently involved in further 5 approved hAEC clinical trials. She leads a cell manufacturing team responsible for GMP-compliant production, release and formulation of allogeneic hAECs for clinical use. A/Prof Lim has since progressed her work to developing a program of cell-free exosome-based therapeutics to address the challenges associated with logistics of clinical delivery, complexities of manufacturing and cost of goods in order to improve patient access and facilitate regulatory approval. This was the subject of her successful NHMRC Level 2 Industry CDF (2019-2022) where her application was ranked highest in Australia, earning her the NHMRC Research Excellence Award.
Find out more about A/Prof Rebecca Lim.